Specjalistyczna Praktyka Lekarska dr med. Marek Horyński
- Address
- ul. B. Chrobrego 6/8, 81-756 Sopot, Poland
Specjalistyczna Praktyka Lekarska dr med. Marek Horyński - Inflammatory Bowel Disease Research Center
Dr. Marek Horyński's specialized medical practice is dedicated to advancing the treatment of inflammatory bowel diseases through innovative clinical research. The center focuses on evaluating novel therapeutic approaches for patients with ulcerative colitis, particularly those experiencing moderate to severe disease activity who require advanced treatment options.
- Phase 2 and long-term efficacy studies of novel biologics and small molecules for ulcerative colitis
- Histologic improvement assessment and objective disease outcome measures
- Long-term safety monitoring and maintenance therapy evaluation in inflammatory bowel disease
The practice demonstrates expertise in conducting both early-phase and long-term extension studies, with particular emphasis on patient safety monitoring and comprehensive efficacy evaluation. The center's research portfolio includes investigations of innovative mechanisms of action, such as sphingosine 1-phosphate receptor modulators and other targeted therapies, contributing to the development of next-generation treatments for moderately to severely active ulcerative colitis.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Celgene International II SARL3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specjalistyczna Praktyka Lekarska dr med. Marek Horyński
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of MORF-057 Efficacy, Safety, and Tolerability in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2a Open-label Study | Morphic Therapeutic Inc. | Phase II | Not Recruiting | Jul 2022 | Feb 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ozanimod | 3 | Unknown | 2015-07-16 | 2018-10-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.